1. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365:331-340.
2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines (REPRINTED) Arch Intern Med/Vol 166, Nov 13, 2006
3. De Charro FTh, Nieuwenhuizen MGM, Ramsteijn PG, et al. Statistical Report 2001. Utrecht, the Netherlands: Stichting RENINE; 2001.
4. United States Renal Data Systems (USRDS). Annual Data Report. United States Renal Data System. Bethesda, Md: National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases; 2004.
5. Geerlings SE, Stolk RP, Camps MJL, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care. 2000;23:744-749.
6. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1997;11:735-750.
7. Hu KK, Boyko EJ, Scholes D, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004;164:989-993.
8. Geerlings SE, Stolk RP, Camps MJL, et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med. 2001;161:1421-1427.
9. Geerlings SE, Meiland R, Van Lith EC, Brouwer EC, Gaastra W, Hoepelman AIM. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care. 2002;25:1405-1409.
10. Mizunoe Y, Matsumoto T, Sakumoto M, et al. Renal scarring by mannose-sensitive adhesin of Escherichia coli type 1 pili. Nephron. 1997;77:412-416.
11. Geerlings SE, Stolk RP, Camps MJL, Netten PM, Collet JT, Hoepelman AIM. Risk factors for symptomatic urinary tract infection in women with diabetes mellitus. Diabetes Care. 2000;23:1737-1741.
12. Medical Research Council Bacteriuria Committee. Recommended terminology of urinary tract infection. BMJ. 1979;2:717-719.
13. Semetkowska E, Horoszek-Maziarz S, Galinski J, Manitius A, Krupa-Wojciechowska B. The clinical course of untreated asymptomatic bacteriuria in diabetic patients: 14-year follow-up. Pol J Med Pharm. 1969;27:91-95.
14. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002;347:1576-1583.
15. Geerlings SE, Brouwer EC, Van Kessel KCPM, Gaastra W, Stolk RP, Hoepelman AIM. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest. 2000;30:995-1001.
16. Kunin CM. The concepts of “significant bacteriuria” and asymptomatic bacteriuria, clinical syndromes and the epidemiology of urinary tract infections. In: Kunin CM, ed. Detection, Prevention and Management of Urinary Tract Infections. 4th ed. Philadelphia, Pa: Lea & Febiger; 1987:57-124.
17. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643-654.
18. Bengtsson C, Bengtsson U, Bjorkelund C, Lincoln K, Sigurdsson JA. Bacteriuria in a population sample of women: 24-year follow-up study: results from the prospective population-based study of women in Gothenburg, Sweden. Scand J Urol Nephrol. 1998;32:284-289.
19. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001; 69:4572-4579.
Traducción y resumen objetivo: Dra. Marta Papponetti. Esp. Medicinta Interna. Docente Aut. UBA. Editora Responsable Med. Interna de Intramed.